MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/00048674231181039

Медицинская библиотека · The Australian and New Zealand journal of psychiatry · 2023

'Quitlink': Outcomes of a randomised controlled trial of peer researcher facilitated referral to a tailored quitline tobacco treatment for people receiving mental health services.

Baker Amanda L, McCarter Kristen, Turner Alyna, Segan Catherine, Castle David, Brophy Lisa, Borland Ron, Kelly Peter J, Bonevski Billie, Baird Donita, Filia Sacha, Attia John, Szwec Stuart, Palazzi Kerrin, White Sarah L, Williams Jill M, Wrobel Anna L, Ireland Andrew, Saxby Karinna, Ghijben Peter, Petrie Dennis, Sweeney Rohan

Рандомизированное исследованиеСтатьяПеревод в очереди

Аннотация

OBJECTIVE

The aim of this study was to test the effectiveness of a tailored quitline tobacco treatment ('Quitlink') among people receiving support for mental health conditions.

METHODS

We employed a prospective, cluster-randomised, open, blinded endpoint design to compare a control condition to our 'Quitlink' intervention. Both conditions received a brief intervention delivered by a peer researcher. Control participants received no further intervention. Quitlink participants were referred to a tailored 8-week quitline intervention delivered by dedicated Quitline counsellors plus combination nicotine replacement therapy. The primary outcome was self-reported 6 months continuous abstinence from end of treatment (8 months from baseline). Secondary outcomes included additional smoking outcomes, mental health symptoms, substance use and quality of life. A within-trial economic evaluation was conducted.

RESULTS

In total, 110 participants were recruited over 26 months and 91 had confirmed outcomes at 8 months post baseline. There was a difference in self-reported prolonged abstinence at 8-month follow-up between Quitlink (16%, n = 6) and control (2%, n = 1) conditions, which was not statistically significant (OR = 8.33 [0.52, 132.09] p = 0.131 available case). There was a significant difference in favour of the Quitlink condition on 7-day point prevalence at 2 months (OR = 8.06 [1.27, 51.00] p = 0.027 available case). Quitlink costs AU$9231 per additional quit achieved.

CONCLUSION

The Quitlink intervention did not result in significantly higher rates of prolonged abstinence at 8 months post baseline. However, engagement rates and satisfaction with the 'Quitlink' intervention were high. While underpowered, the Quitlink intervention shows promise. A powered trial to determine its effectiveness for improving long-term cessation is warranted.

Для цитирования: Baker Amanda L, McCarter Kristen, Turner Alyna, Segan Catherine, Castle David, Brophy Lisa, Borland Ron, Kelly Peter J, Bonevski Billie, Baird Donita, Filia Sacha, Attia John, Szwec Stuart, Palazzi Kerrin, White Sarah L, Williams Jill M, Wrobel Anna L, Ireland Andrew, Saxby Karinna, Ghijben Peter, Petrie Dennis, Sweeney Rohan. 'Quitlink': Outcomes of a randomised controlled trial of peer researcher facilitated referral to a tailored quitline tobacco treatment for people receiving mental health services.. The Australian and New Zealand journal of psychiatry. 2023. DOI: 10.1177/00048674231181039.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.